Nasdaq: BCRX
BioCryst Pharmaceuticals insiders
The officers, directors and 10% owners of BioCryst Pharmaceuticals, Inc. who hold the most stock, valued at the live BCRX price.
$7.32
BCRX today +$20K (+0.27%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their BCRX stock
- $17.9M
- Market value
- $1.88B
- Held by ranked insiders
- 0.95%
Insiders by value of BCRX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jon P. Stonehouse | Director | 1,380,419 | $10.1M | 0.54% | 8715th |
| 2 | Charles K. Gayer | President and CCO | 952,583 | $7.0M | 0.37% | 11429th |
| 3 | Steve Aselage | Director | 72,659 | $532K | <0.1% | 10719th |
| 4 | Steven Frank | Director | 36,747 | $269K | <0.1% | 13776th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for BioCryst Pharmaceuticals; see each profile for the filing.